Quipt Home Medical Corp
QIPT2.740USD
0.000
Close 09/19, 16:00（ET）Quotes delayed by 15 min
119.04MMarket Cap
LossP/E TTM
More Details of Quipt Home Medical Corp Company
Quipt Home Medical Corp. is a home medical equipment provider. The Company provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.
Company Info
Ticker SymbolQIPT
Company nameQuipt Home Medical Corp
IPO dateMar 18, 2014
CEOMr. Gregory (Greg) Crawford
Number of employees- -
Security typeOrdinary Share
Fiscal year-endMar 18
Address1019 Town Drive
CityWILDER
Stock exchangeThe Toronto Stock Exchange
CountryUnited States of America
Postal code41076
Phone18598782220
Websitehttps://quipthomemedical.com/
Ticker SymbolQIPT
IPO dateMar 18, 2014
CEOMr. Gregory (Greg) Crawford
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Hardik Mehta
Mr. Hardik Mehta
Chief Financial Officer
Chief Financial Officer
1.16M
+46.29%
Mr. Mark Miles
Mr. Mark Miles
Chief Compliance Officer
Chief Compliance Officer
110.00K
--
Mr. Patrick Gamble
Mr. Patrick Gamble
Executive Vice President - Operations
Executive Vice President - Operations
60.06K
+49.93%
Mr. Gregory (Greg) Crawford
Mr. Gregory (Greg) Crawford
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Mark Greenberg
Mr. Mark Greenberg
Independent Director
Independent Director
--
--
Mr. David Bachelder
Mr. David Bachelder
Executive Vice President - Operations
Executive Vice President - Operations
--
--
Dr. Kevin A. Carter
Dr. Kevin A. Carter
Independent Director
Independent Director
--
--
Mr. Cole Stevens
Mr. Cole Stevens
Vice President - Corporate Development
Vice President - Corporate Development
--
--
Mr. Thomas W. Roehrig
Mr. Thomas W. Roehrig
Chief Accounting Officer
Chief Accounting Officer
--
--
Mr. Brian J. Wessel
Mr. Brian J. Wessel
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Hardik Mehta
Mr. Hardik Mehta
Chief Financial Officer
Chief Financial Officer
1.16M
+46.29%
Mr. Mark Miles
Mr. Mark Miles
Chief Compliance Officer
Chief Compliance Officer
110.00K
--
Mr. Patrick Gamble
Mr. Patrick Gamble
Executive Vice President - Operations
Executive Vice President - Operations
60.06K
+49.93%
Mr. Gregory (Greg) Crawford
Mr. Gregory (Greg) Crawford
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Mark Greenberg
Mr. Mark Greenberg
Independent Director
Independent Director
--
--
Mr. David Bachelder
Mr. David Bachelder
Executive Vice President - Operations
Executive Vice President - Operations
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Sat, Aug 23
Updated: Sat, Aug 23
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Claret Asset Management Corporation
9.75%
Forager Capital Management, LLC
9.67%
Crawford (Gregory John)
9.22%
Kanen Wealth Management, LLC
4.44%
First Manhattan Co. LLC
3.80%
Other
63.12%
Shareholders
Shareholders
Proportion
Claret Asset Management Corporation
9.75%
Forager Capital Management, LLC
9.67%
Crawford (Gregory John)
9.22%
Kanen Wealth Management, LLC
4.44%
First Manhattan Co. LLC
3.80%
Other
63.12%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
21.23%
Investment Advisor
19.95%
Individual Investor
15.18%
Hedge Fund
3.68%
Research Firm
1.66%
Private Equity
1.17%
Bank and Trust
0.47%
Venture Capital
0.09%
Other
36.57%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
205
30.42M
70.02%
-4.48M
2025Q1
222
32.65M
75.41%
-3.29M
2024Q4
219
27.04M
62.76%
-4.70M
2024Q3
209
25.69M
59.64%
-2.81M
2024Q2
198
23.34M
54.85%
-1.55M
2024Q1
194
21.73M
51.56%
-2.58M
2023Q4
189
20.79M
49.92%
-2.91M
2023Q3
186
21.87M
52.48%
+145.17K
2023Q2
175
20.15M
48.43%
+2.87M
2023Q1
115
15.73M
43.04%
+2.14M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Claret Asset Management Corporation
4.32M
9.93%
-74.19K
-1.69%
May 31, 2025
Forager Capital Management, LLC
4.20M
9.67%
--
--
Jun 04, 2025
Crawford (Gregory John)
4.01M
9.22%
+1.05M
+35.73%
Mar 22, 2025
Kanen Wealth Management, LLC
1.93M
4.44%
-1.04M
-35.07%
May 27, 2025
First Manhattan Co. LLC
1.65M
3.8%
--
--
Mar 31, 2025
Mehta (Hardik)
1.16M
2.67%
+366.47K
+46.29%
Mar 22, 2025
Royce Investment Partners
1.95M
4.49%
-32.10K
-1.62%
Mar 31, 2025
Putnam Investment Management, L.L.C.
703.72K
1.62%
-26.10K
-3.58%
Mar 31, 2025
Arrowstreet Capital, Limited Partnership
578.92K
1.33%
+85.06K
+17.22%
Mar 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
